Bristol-Myers Squibb Rights
CELG.RT
22 hedge funds and large institutions have $1.22M invested in Bristol-Myers Squibb Rights in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0.02% less ownership
Funds ownership: 0.02% → 0% (-0.02%)
8% less funds holding
Funds holding: 24 → 22 (-2)
44% less capital inflows, than outflows
Capital inflows: $26.4K | Capital outflows: $47.6K
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$26.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9 |
| 3 |
AE Wealth Management
Topeka,
Kansas
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Maven Securities
St Helier,
Jersey
|
-$46.8K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$392 |
| 3 |
Two Sigma Securities
New York
|
-$302 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$86 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$1 |
CELG.RT Hedge Fund Activity: Q3 2025 in Review
22 of the 7,650 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q3 2025, worth a combined $1.22M — up 2,016% from $57.9K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CELG.RT and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $26.4K. The largest seller was Maven Securities, exiting entirely with an estimated $46.8K sold.
- 22 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q3 2025, down from 24 in Q2 2025.
- Funds reported $1.22M of Bristol-Myers Squibb Rights stock for Q3 2025, up 2,016% quarter-over-quarter.
- 2 funds opened new Bristol-Myers Squibb Rights positions in Q3 2025 and 4 closed out, a net change of -2 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q3 2025 was Toronto Dominion Bank, an estimated $26.4K added.
- The largest Bristol-Myers Squibb Rights seller in Q3 2025 was Maven Securities, an estimated $46.8K sold.
Based on aggregated 13F filings for Q3 2025.